Enhancing Bioactive Compound Production in Withania somnifera Through Tissue Culture and Hairy Root Technologies: Overcoming Propagation and Yield Barriers
Implementing Organization
Csir-Institute Of Himalayan Bioresource Technology(Csir-Ihbt), Palampur
Principal Investigator
Dr. Kapil Deswal
Csir-Institute Of Himalayan Bioresource Technology(Csir-Ihbt), Palampur
Kapildeswal3@gmail.com
Project Overview
Ashwagandha (Withania somnifera) is a well-known medicinal plant that is prized for its healing withanolides. Low seed viability, low germination rates, and genetic variability are problems with conventional propagation techniques that make it difficult to produce high-quality plant material consistently. Despite the potential of in vitro culture techniques, current tissue culture methodologies are not very scalable and frequently do not produce bioactive metabolites in a stable and high-yield manner.
One of the most important herbs in Ayurvedic therapy is ashwagandha (Withania somnifera), which has anti-inflammatory, neuroprotective, and adaptogenic qualities. Withanolides and withaferin-A, which are abundant in its roots and contribute to its medicinal properties, are native to desert parts of India and the Middle East. Modern research backs up its traditional use to increase vitality and manage fatigue as well as its ability to lower stress, improve cognitive function, improve physical performance, and alter immunological responses. At ideal dosages, it also has antidiabetic, cardioprotective, and antioxidant properties, which are beneficial for male fertility.
The goal of this project is to improve and develop plant tissue culture methods for ashwagandha in order to increase the yield of withanolides and other beneficial phytochemicals. The research will create cell suspension and hairy root cultures, design effective micropropagation procedures utilizing a variety of explants, and examine the impact of elicitors and precursor feeding on metabolite synthesis. In order to assess the consistency and improvement of bioactive chemical production, the proposal also includes comparative profiling of in vitro and in vivo tissues using chromatographic and spectrometric methods.
The study will also examine the role of plant growth regulators, light conditions, and carbon sources in regulating somatic embryogenesis and secondary metabolite pathways. Molecular techniques such as qRT-PCR will be used to monitor the expression of key biosynthetic genes in various culture systems. The ultimate goal is to develop a reproducible, scalable, and cost-effective in vitro system for mass production of high-quality Ashwagandha biomass with elevated different secondary metabolites content. Outcomes from this research will fill critical gaps in existing tissue culture practices for medicinal plants and offer sustainable solutions for the standardized production of Ashwagandha-based phytopharmaceuticals.